IRIS Accounts Production v25.1.4.42 10038647 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100386472024-03-31100386472025-03-31100386472024-04-012025-03-31100386472023-03-31100386472023-04-012024-03-31100386472024-03-3110038647ns15:EnglandWales2024-04-012025-03-3110038647ns14:PoundSterling2024-04-012025-03-3110038647ns10:Director12024-04-012025-03-3110038647ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3110038647ns10:SmallEntities2024-04-012025-03-3110038647ns10:AuditExemptWithAccountantsReport2024-04-012025-03-3110038647ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3110038647ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3110038647ns10:FullAccounts2024-04-012025-03-3110038647ns10:OrdinaryShareClass12024-04-012025-03-3110038647ns10:Director22024-04-012025-03-3110038647ns10:Director32024-04-012025-03-3110038647ns10:Director42024-04-012025-03-3110038647ns10:RegisteredOffice2024-04-012025-03-3110038647ns5:CurrentFinancialInstruments2025-03-3110038647ns5:CurrentFinancialInstruments2024-03-3110038647ns5:ShareCapital2025-03-3110038647ns5:ShareCapital2024-03-3110038647ns5:RetainedEarningsAccumulatedLosses2025-03-3110038647ns5:RetainedEarningsAccumulatedLosses2024-03-3110038647ns5:PlantMachinery2024-04-012025-03-3110038647ns5:PlantMachinery2024-03-3110038647ns5:PlantMachinery2025-03-3110038647ns5:PlantMachinery2024-03-3110038647ns5:AdditionsToInvestments2025-03-3110038647ns5:CostValuation2025-03-3110038647ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3110038647ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110038647ns10:OrdinaryShareClass12025-03-31
REGISTERED NUMBER: 10038647 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Hampshire Vascular Access Ltd

Hampshire Vascular Access Ltd (Registered number: 10038647)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Report of the Accountants 6

Hampshire Vascular Access Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Dr J W Knight
Dr S J Carman
Miss O Knight
Miss K Knight





REGISTERED OFFICE: 3 Clover House
Boston Road
Sleaford
Lincolnshire
NG34 7HD





REGISTERED NUMBER: 10038647 (England and Wales)





ACCOUNTANTS: D Hubbard Accountancy Limited
3 Clover House
Boston Road
Sleaford
Lincolnshire
NG34 7HD

Hampshire Vascular Access Ltd (Registered number: 10038647)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 32,828 41,504
Investments 5 3,500 -
36,328 41,504

CURRENT ASSETS
Debtors 6 45,214 53,135
Cash at bank 368,582 291,854
413,796 344,989
CREDITORS
Amounts falling due within one year 7 26,750 29,649
NET CURRENT ASSETS 387,046 315,340
TOTAL ASSETS LESS CURRENT
LIABILITIES

423,374

356,844

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 423,274 356,744
SHAREHOLDERS' FUNDS 423,374 356,844

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 December 2025 and were signed on its behalf by:




Dr J W Knight - Director


Hampshire Vascular Access Ltd (Registered number: 10038647)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Hampshire Vascular Access Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Hampshire Vascular Access Ltd (Registered number: 10038647)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 65,340
Additions 2,268
At 31 March 2025 67,608
DEPRECIATION
At 1 April 2024 23,836
Charge for year 10,944
At 31 March 2025 34,780
NET BOOK VALUE
At 31 March 2025 32,828
At 31 March 2024 41,504

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 3,500
At 31 March 2025 3,500
NET BOOK VALUE
At 31 March 2025 3,500

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 41,614 48,708
Other debtors 3,600 4,427
45,214 53,135

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Tax 22,446 10,134
Social security and other taxes 338 108
Directors' current accounts 2,286 17,757
Accrued expenses 1,680 1,650
26,750 29,649

Hampshire Vascular Access Ltd (Registered number: 10038647)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
100 Ordinary 1 100 100

9. RELATED PARTY DISCLOSURES

During the year, total dividends of £1,000 (2024 - £2,000) were paid to the directors .

Hampshire Vascular Access Ltd

Report of the Accountants to the Directors of
Hampshire Vascular Access Ltd

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 March 2025 set out on pages two to five and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






D Hubbard Accountancy Limited
3 Clover House
Boston Road
Sleaford
Lincolnshire
NG34 7HD


2 December 2025